Table 2.
Characteristics of patients in the training and validation sets at baseline
| Variable | Training set(n = 208) | Validation set(n = 83) | P value | ||
|---|---|---|---|---|---|
| Age (year) | 52(44,62) | 55(44,64) | 0.897 | ||
| Male sex (%) | 84(40.4%) | 35(42.2%) | 0.780 | ||
|
Ascites (%) Esophagogastric Varices (%) Hepatic Encephalopathy (%) |
98(47.1%) 100(48.1%) 83(39.9%) |
38(45.8%) 33(39.8%) 24(28.9%) |
0.837 0.240 0.082 |
||
| Viral hepatitis B (%) | 75(36.1%) | 24(28.9%) | 0.246 | ||
| LS (kPa) | 30.6(20.4,41.7) | 30.8(19.1,41.0) | 0.821 | ||
| SS (kPa) | 55.2(39.0,73.0) | 54.0(38.8,72.4) | 0.746 | ||
| PLT (10^9/L) | 93.0(77.2,144.2) | 95.5(79.3,140.0) | 0.579 | ||
| ALT (U/L) | 57.6(45.9,71.2) | 60.0(46.8,73.6) | 0.979 | ||
| AST (U/L) | 64.0(44.4,83.0) | 63.5(43.9,81.5) | 0.834 | ||
| APRI | 1.80(0.90,2.48) | 1.70(0.89,2.43) | 0.864 | ||
| FIB-4 | 4.65(2.73,6.43) | 4.60(2.75,6.47) | 0.572 | ||
| Hb (g/L) | 85.6(67.0,100.0) | 84.3(64.9,101.0) | 0.921 | ||
| ALB (g/L) | 33.9(27.6,38.3) | 33.9(27.7,37.9) | 0.794 | ||
| TBIL (umol/L) | 34.9(24.1,53.2) | 34.8(22.8,50.1) | 0.617 | ||
| Scr (umol/L) | 53.7(41.1,70.8) | 54.4(41.1,74.4) | 0.952 | ||
| FIB (g/L) | 1.82(1.39,2.40) | 1.78(1.34,2.43) | 0.614 | ||
| TC (mmol/L) | 3.18(2.96,3.31) | 3.19(2.89,3.42) | 0.515 | ||
| PT (s) | 15.1(12.8,16.7) | 14.8(12.7,16.8) | 0.642 |
Quantitative variables are expressed as median (25th percentile; 75th percentile)
Categorical variables are expressed as numbers (percentages)